ETF龙虎榜 | 霸屏！涨幅榜前十 全是它

Group 1: Innovation Drug ETFs Performance - On October 31, innovation drug-themed ETFs collectively surged, with the top ten ETFs all being innovation drug-themed, each rising over 5% [1][2] - The top performers included the Science and Technology Innovation Drug ETFs from Huatai and Guotai, both exceeding 7% gains [2][3] - The Hong Kong Stock Connect Innovation Drug ETFs also showed strong performance, with gains over 5% [2][3] Group 2: Market Activity and Trends - On October 31, 11 ETFs had trading volumes exceeding 10 billion yuan, including several bond ETFs and cross-border ETFs like the Hong Kong Stock Connect Innovation Drug ETF [1][6] - On October 30, several industry ETFs, including securities, Hong Kong innovation drug, and medical ETFs, saw significant net inflows [8][9] - The previous trading day, broad-based ETFs experienced substantial net inflows, with those tracking the CSI 500 seeing over 1.1 billion yuan [8][9] Group 3: Decline in Communication Equipment ETFs - On October 31, communication equipment ETFs and communication ETFs led the decline, both dropping over 5% [4][5] - Specific ETFs such as the 5GETF and semiconductor equipment ETFs also experienced declines exceeding 4% [4][5] Group 4: Investment Opportunities in Innovation Drugs - The investment outlook for innovation drugs remains positive, with potential catalysts in the fourth quarter that could reactivate market sentiment [10] - The biotech sector in China is positioned as a key choice for multinational pharmaceutical companies due to its engineering talent and cost advantages [10] - The trend of domestic brands expanding internationally, particularly in sectors like automotive and innovation drugs, is expected to open up further market opportunities [10]